---
title: "HIE-Based Near-Real-Time Platform for Population Infectious Disease Surveillance"
id: "medrxiv-19-development-and-evaluation-of-a-regional-health-information-exchange-hie-based"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-19-development-and-evaluation-of-a-regional-health-information-exchange-hie-based"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.04.26364717v1?rss=1"
published_at: "2026-10-06T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# HIE-Based Near-Real-Time Platform for Population Infectious Disease Surveillance
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-19-development-and-evaluation-of-a-regional-health-information-exchange-hie-based
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.04.26364717v1?rss=1)
- **Published At:** 2026-10-06T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study developed an end-to-end informatics pipeline using a regional **Health Information Exchange (HIE)** in Southeast Texas to support near-real-time, population-level infectious disease surveillance. - Deidentified individual-level cases of **COVID-19**, **influenza**, and **RSV** were identified from electronic health record data using diagnosis codes and laboratory results. - The surveillance window covered January 2022 through August 2026 and captured 492,242 COVID-19 cases, 343,977 influenza cases, and 33,159 RSV cases during that period. - The HIE-based dataset reproduced expected seasonal patterns, including winter peaks for COVID-19 and influenza, and documented changing RSV epidemiology across the study period. - The platform enabled monitoring of laboratory test positivity metrics and hospitalization trends stratified by age groups. - The project demonstrates that HIE infrastructure can deliver scalable, standardized, and timely population health indicators that complement traditional public health surveillance systems. - Ethical oversight: the project used deidentified EHR data and was approved by the University of Texas Health Science Center at Houston Committee for Protection of Human Subjects as a public health project with a waiver of informed consent (Study HSC-IMM-24-0381). - Data are not publicly shareable due to confidentiality; requests for deidentified data can be directed to cphs@uth.tmc.edu and will be evaluated case-by-case under institutional policy. - Funding context lists S.B. 1780, 87th Legislature, 2021 Regular Session (Texas 2021) among declared funder information. - The article is a medRxiv preprint posted October 06, 2026 and has not been peer reviewed; authors declared no competing interests.
## Clinical Analysis & Structured Key Points
Development and Evaluation of a Regional Health Information Exchange (HIE)-Based Platform for Population-Level Infectious Disease Surveillance | medRxiv Skip to main content Development and Evaluation of a Regional Health Information Exchange (HIE)-Based Platform for Population-Level Infectious Disease Surveillance View ORCID Profile Micaela Sandoval , Jennifer Mikhail , Hao He , Courtney Denton , Haider al Rustem , Catherine Troisi , Tru Cao , Jennifer Deegan , Blake Hanson , Cici Bauer , Eric Boerwinkle doi: https://doi.org/10.64898/2026.10.04.26364717 Micaela Sandoval 1 University of Texas Health Science Center at Houston School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Micaela Sandoval For correspondence: micaela.n.sandoval{at}uth.tmc.edu Jennifer Mikhail 2 Healthconnect Texas; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hao He 1 University of Texas Health Science Center at Houston School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Courtney Denton 1 University of Texas Health Science Center at Houston School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Haider al Rustem 1 University of Texas Health Science Center at Houston School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Catherine Troisi 1 University of Texas Health Science Center at Houston School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Tru Cao 1 University of Texas Health Science Center at Houston School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jennifer Deegan 1 University of Texas Health Science Center at Houston School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Blake Hanson 3 University of Texas Health Sciences Center at Houston; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Cici Bauer 1 University of Texas Health Science Center at Houston School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Eric Boerwinkle 4 University of Texas Health Science Center at Houston Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Data/Code Preview PDF Abstract Background: Health Information Exchanges (HIEs) offer a potential resource for timely, population-level infectious disease surveillance by integrating electronic health record data across healthcare systems. Methods: We developed an end-to-end informatics pipeline for near-real-time community-level health surveillance based in a regional HIE serving Southeast Texas. We identified deidentified individual-level COVID-19, influenza, and RSV cases using diagnosis codes and laboratory results and assessed demographic and temporal trends from January 2022 through August 2026. Results: We identified 492,242 COVID-19 cases, 343,977 influenza cases, and 33,159 RSV cases during the study period. Surveillance data captured expected seasonal patterns, including recurring winter COVID-19 and influenza peaks and shifting RSV epidemiology, while enabling monitoring of laboratory test positivity metrics and hospitalization trends across age groups. Conclusions: HIE-based surveillance provides scalable, near-real-time monitoring of disease targets across large populations. HIE infrastructure can enhance public health situational awareness and complement traditional surveillance systems by harmonizing vital health data across systems and providers and delivering timely, standardized, and representative population health indicators. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study using deidentified EHR data for infectious disease monitoring was approved by the University of Texas Health Science Center at Houston Committee for Protection of Human Subjects as a public health project and granted a waiver of informed consent (Study number: HSC-IMM-24-0381). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The datasets presented in this article are not readily available because clinical data cannot be shared publicly because of patient confidentiality concerns as imposed by the University of Texas Health Science Center at Houston Committee for the Protection of Human Subjects. Requests to access de-identified data can be made to cphs{at}uth.tmc.edu which will be evaluated on a case by case basis in line with institutional policies. Funder Information Declared S.B. 1780, 87th Legislature, 2021 Reg. Sess. (Texas 2021) Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Back to top Previous Next Posted October 06, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Development and Evaluation of a Regional Health Information Exchange (HIE)-Based Platform for Population-Level Infectious Disease Surveillance Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Development and Evaluation of a Regional Health Information Exchange (HIE)-Based Platform for Population-Level Infectious Disease Surveillance Micaela Sandoval , Jennifer Mikhail , Hao He , Courtney Denton , Haider al Rustem , Catherine Troisi , Tru Cao , Jennifer Deegan , Blake Hanson , Cici Bauer , Eric Boerwinkle medRxiv 2026.10.04.26364717; doi: https://doi.org/10.64898/2026.10.04.26364717 Share This Article: Copy Citation Tools Development and Evaluation of a Regional Health Information Exchange (HIE)-Based Platform for Population-Level Infectious Disease Surveillance Micaela Sandoval , Jennifer Mikhail , Hao He , Courtney Denton , Haider al Rustem , Catherine Troisi , Tru Cao , Jennifer Deegan , Blake Hanson , Cici Bauer , Eric Boerwinkle medRxiv 2026.10.04.26364717; doi: https://doi.org/10.64898/2026.10.04.26364717 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Epidemiology Subject Areas All Articles Addiction Medicine (626) Allergy and Immunology (914) Anesthesia (340) Cardiovascular Medicine (4886) Dentistry and Oral Medicine (486) Dermatology (421) Emergency Medicine (659) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1646) Epidemiology (16067) Forensic Medicine (34) Gastroenterology (1218) Genetic and Genomic Medicine (7129) Geriatric Medicine (737) Health Economics (1073) Health Informatics (5128) Health Policy (1447) Health Systems and Quality Improvement (1793) Hematology (591) HIV/AIDS (1355) Infectious Diseases (except HIV/AIDS) (16361) Intensive Care and Critical Care Medicine (1185) Medical Education (678) Medical Ethics (156) Nephrology (729) Neurology (7389) Nursing (371) Nutrition (1102) Obstetrics and Gynecology (1263) Occupational and Environmental Health (1010) Oncology (3660) Ophthalmology (1067) Orthopedics (399) Otolaryngology (460) Pain Medicine (484) Palliative Medicine (142) Pathology (711) Pediatrics (1823) Pharmacology and Therapeutics (741) Primary Care Research (777) Psychiatry and Clinical Psychology (5988) Public and Global Health (9838) Radiology and Imaging (2467) Rehabilitation Medicine and Physical Therapy (1479) Respiratory Medicine (1257) Rheumatology (652) Sexual and Reproductive Health (786) Sports Medicine (588) Surgery (786) Toxicology (107) Transplantation (310) Urology (299)
## Related Clinical Research

- [Helen Branswell, veteran infectious disease reporter at STAT, dies at 69](https://medichelpline.com/clinical-feed/stat-news-0-helen-branswell-whose-reporting-on-infectious-diseases-and-public-health-drew.md)
- [Immunogenicity of Sequential Conjugate and Non-Conjugate Pneumococcal Vaccination in Dialysis and](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-immunogenicity-of-sequential-conjugate-and-non-conjugate-pneumococcal.md)
- [Vaxcyte’s VAX-31 meets Phase 3 endpoints; FDA delays Novo Nordisk hemophilia A review over manufac](https://medichelpline.com/clinical-feed/stat-news-1-stat-pharmalittle-we-re-reading-about-a-vaxcyte-pneumococcal-shot-increasing.md)
- [Increased risk of acute gastroenteritis after COVID-19 hospitalisation: a retrospective England an](https://medichelpline.com/clinical-feed/medrxiv-3-risk-of-acute-gastroenteritis-following-covid-19-exposure-a-retrospective.md)
- [Post-pandemic shifts in respiratory pathogen circulation: Six-year FilmArray® surveillance in Toky](https://medichelpline.com/clinical-feed/medrxiv-18-post-pandemic-ecological-reshaping-of-respiratory-pathogen-circulation-a-six.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.